Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor
Abstract Background Erythropoietin (EPO) is a hypoxia-inducible stimulator of erythropoiesis. Besides its traditional application in anemia therapy, it offers an effective treatment in the cancer patients, especially those who receive chemotherapy. Several reports indicated that it could promote the...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2017-12-01
|
| Seri Bilgileri: | Cancer Cell International |
| Konular: | |
| Online Erişim: | http://link.springer.com/article/10.1186/s12935-017-0494-7 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|